Analytical characterization study· 2015

Identification of the small research tetra peptide Epitalon, assumed to be a potential treatment for cancer, old age and Retinitis Pigmentosa in two illegal pharmaceutical preparations

Vanhee C; Moens G; Van Hoeck E; Deconinck E; De Beer JO

Drug testing and analysis

DOI
10.1002/dta.1771
PubMed
25535022
Evidence level
analytical
Verification
rejected

Summary

Vanhee et al. 2015 analytical/forensic paper (Drug Testing and Analysis) identifying the tetrapeptide Epitalon in two seized illegal pharmaceutical preparations; no biological, mechanistic, or clinical data on Epitalon itself.

Limitations

PubMed record supplies no abstract text (title-plus-DOI only); the paper's purpose is analytical identification of an illicit substance in seized products; it makes no claim about Epitalon biology or clinical use.

Linked peptides

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.